A case of "retained products of conception" treated with hysteroscopic surgery occurring after cesarean delivery in a patient who underwent fertility-preserving therapy for endometrial cancer-Reference-Cited by-同舟云学术

A case of "retained products of conception" treated with hysteroscopic surgery occurring after cesarean delivery in a patient who underwent fertility-preserving therapy for endometrial cancer

Published:2020 Issue:2 Volume:36 Page:317-321
ISSN:1884-5746
Container-title:JAPANESE JOURNAL OF GYNECOLOGIC AND OBSTETRIC ENDOSCOPY
language:en
Short-container-title:JAPANESE JOURNAL OF JSGOE

Author:

Makabe Takeshi¹,Yamagami Wataru¹,Hirano Takuro¹,Sakai Kensuke¹,Chiyoda Tatsuyuki¹,Kataoka Fumio¹,Aoki Daisuke¹

Affiliation:

1. Department of Obstetrics and Gynecology, Keio University School of Medicine

Publisher

Japan Society of Gynecologic and Obstetric Endoscopy and Minimally Invasive Therapy

Subject

General Engineering

Link

https://www.jstage.jst.go.jp/article/jsgoe/36/2/36_317/_pdf

Reference8 articles.

1. 2) Yamagami W, et al: Is repeated high-dose medroxyprogesterone acetate (MPA) therapy permissible for patients with early stage endometrial cancer or atypical endometrial hyperplasia who desire preserving fertility? J Gynecol Oncol. 2018; 29: e21.

2. 3) Wolman I, et al.: Combined clinical and ultarasonographic work-up for the diagnosis of retained products of conception. Fertil Steril. 2009; 92: 1162-1164.

3. 4) Dombrowski MP, et al.: Third stage of lobor: analysis of duration and clinical practice. Am J Obse Gynecol. 1995; 172: 1279-1284.

4. 7) Gallos ID, et al. Regression, relapse, and live birth rates with fertility-sparing therapy for endometrial cancer and atypical complex endometrial hyperplasia: a systematic review and metaanalysis. Am J Obstet Gynecol. 2012; 207: 266.e1-12.

5. 8) Wang CJ, et al. Fertility-preserving treatment in young women with endometrial adenocarcinoma: a long-term cohort study. Int J Gynecol Cancer. 2014; 24: 718-28.